1 Seasonal Influenza Vaccines Market Overview 1.1 Product Overview and Scope of Seasonal Influenza Vaccines 1.2 Seasonal Influenza Vaccines Segment by Type 1.2.1 Global Seasonal Influenza Vaccines Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Type A (H1N1) 1.2.3 Type A (H3N2) 1.2.4 Type B 1.3 Seasonal Influenza Vaccines Segment by Application 1.3.1 Global Seasonal Influenza Vaccines Sales Comparison by Application: (2021-2027) 1.3.2 Pediatrics 1.3.3 Adolescence 1.3.4 Adults 1.3.5 Elderly 1.4 Global Seasonal Influenza Vaccines Market Size Estimates and Forecasts 1.4.1 Global Seasonal Influenza Vaccines Revenue 2016-2027 1.4.2 Global Seasonal Influenza Vaccines Sales 2016-2027 1.4.3 Seasonal Influenza Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027 2 Seasonal Influenza Vaccines Market Competition by Manufacturers 2.1 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2016-2021) 2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Seasonal Influenza Vaccines Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Seasonal Influenza Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Seasonal Influenza Vaccines Market Competitive Situation and Trends 2.5.1 Seasonal Influenza Vaccines Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Seasonal Influenza Vaccines Players Market Share by Revenue 2.5.3 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Seasonal Influenza Vaccines Retrospective Market Scenario by Region 3.1 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Seasonal Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Seasonal Influenza Vaccines Market Facts & Figures by Country 3.3.1 North America Seasonal Influenza Vaccines Sales by Country 3.3.2 North America Seasonal Influenza Vaccines Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country 3.4.1 Europe Seasonal Influenza Vaccines Sales by Country 3.4.2 Europe Seasonal Influenza Vaccines Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Seasonal Influenza Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Seasonal Influenza Vaccines Sales by Region 3.5.2 Asia Pacific Seasonal Influenza Vaccines Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Seasonal Influenza Vaccines Market Facts & Figures by Country 3.6.1 Latin America Seasonal Influenza Vaccines Sales by Country 3.6.2 Latin America Seasonal Influenza Vaccines Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Seasonal Influenza Vaccines Sales by Country 3.7.2 Middle East and Africa Seasonal Influenza Vaccines Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Seasonal Influenza Vaccines Historic Market Analysis by Type 4.1 Global Seasonal Influenza Vaccines Sales Market Share by Type (2016-2021) 4.2 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2016-2021) 4.3 Global Seasonal Influenza Vaccines Price by Type (2016-2021) 5 Global Seasonal Influenza Vaccines Historic Market Analysis by Application 5.1 Global Seasonal Influenza Vaccines Sales Market Share by Application (2016-2021) 5.2 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2016-2021) 5.3 Global Seasonal Influenza Vaccines Price by Application (2016-2021) 6 Key Companies Profiled 6.1 GlaxoSmithKline plc 6.1.1 GlaxoSmithKline plc Corporation Information 6.1.2 GlaxoSmithKline plc Description and Business Overview 6.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio 6.1.5 GlaxoSmithKline plc Recent Developments/Updates 6.2 Sinovac Biotech Ltd 6.2.1 Sinovac Biotech Ltd Corporation Information 6.2.2 Sinovac Biotech Ltd Description and Business Overview 6.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio 6.2.5 Sinovac Biotech Ltd Recent Developments/Updates 6.3 Changsheng Bio-Technology 6.3.1 Changsheng Bio-Technology Corporation Information 6.3.2 Changsheng Bio-Technology Description and Business Overview 6.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio 6.3.5 Changsheng Bio-Technology Recent Developments/Updates 6.4 Ccbio SA 6.4.1 Ccbio SA Corporation Information 6.4.2 Ccbio SA Description and Business Overview 6.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio 6.4.5 Ccbio SA Recent Developments/Updates 6.5 Aleph Biomedical 6.5.1 Aleph Biomedical Corporation Information 6.5.2 Aleph Biomedical Description and Business Overview 6.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio 6.5.5 Aleph Biomedical Recent Developments/Updates 6.6 Sanofi 6.6.1 Sanofi Corporation Information 6.6.2 Sanofi Description and Business Overview 6.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Sanofi Seasonal Influenza Vaccines Product Portfolio 6.6.5 Sanofi Recent Developments/Updates 6.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical 6.6.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information 6.6.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview 6.6.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio 6.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates 6.8 Dalian Hissen Bio-pharm 6.8.1 Dalian Hissen Bio-pharm Corporation Information 6.8.2 Dalian Hissen Bio-pharm Description and Business Overview 6.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio 6.8.5 Dalian Hissen Bio-pharm Recent Developments/Updates 6.9 Abbott Laboratories 6.9.1 Abbott Laboratories Corporation Information 6.9.2 Abbott Laboratories Description and Business Overview 6.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio 6.9.5 Abbott Laboratories Recent Developments/Updates 6.10 Novartis International AG 6.10.1 Novartis International AG Corporation Information 6.10.2 Novartis International AG Description and Business Overview 6.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio 6.10.5 Novartis International AG Recent Developments/Updates 7 Seasonal Influenza Vaccines Manufacturing Cost Analysis 7.1 Seasonal Influenza Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Seasonal Influenza Vaccines 7.4 Seasonal Influenza Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Seasonal Influenza Vaccines Distributors List 8.3 Seasonal Influenza Vaccines Customers 9 Seasonal Influenza Vaccines Market Dynamics 9.1 Seasonal Influenza Vaccines Industry Trends 9.2 Seasonal Influenza Vaccines Growth Drivers 9.3 Seasonal Influenza Vaccines Market Challenges 9.4 Seasonal Influenza Vaccines Market Restraints 10 Global Market Forecast 10.1 Seasonal Influenza Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Seasonal Influenza Vaccines by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Seasonal Influenza Vaccines by Type (2022-2027) 10.2 Seasonal Influenza Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Seasonal Influenza Vaccines by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Seasonal Influenza Vaccines by Application (2022-2027) 10.3 Seasonal Influenza Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Seasonal Influenza Vaccines by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Seasonal Influenza Vaccines by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Seasonal Influenza Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Seasonal Influenza Vaccines Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Seasonal Influenza Vaccines Covered in This Study Table 5. Global Seasonal Influenza Vaccines Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2016-2021) Table 7. Global Seasonal Influenza Vaccines Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Seasonal Influenza Vaccines Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Seasonal Influenza Vaccines Manufacturing Sites and Area Served Table 11. Manufacturers Seasonal Influenza Vaccines Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccines as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Seasonal Influenza Vaccines Sales by Region (2016-2021) & (K Units) Table 16. Global Seasonal Influenza Vaccines Sales Market Share by Region (2016-2021) Table 17. Global Seasonal Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units) Table 19. North America Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021) Table 20. North America Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021) Table 22. Europe Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units) Table 23. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021) Table 24. Europe Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Seasonal Influenza Vaccines Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Seasonal Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Seasonal Influenza Vaccines Revenue Market Share by Region (2016-2021) Table 30. Latin America Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units) Table 31. Latin America Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021) Table 32. Latin America Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Seasonal Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Seasonal Influenza Vaccines Revenue Market Share by Country (2016-2021) Table 38. Global Seasonal Influenza Vaccines Sales (K Units) by Type (2016-2021) Table 39. Global Seasonal Influenza Vaccines Sales Market Share by Type (2016-2021) Table 40. Global Seasonal Influenza Vaccines Revenue (Million US$) by Type (2016-2021) Table 41. Global Seasonal Influenza Vaccines Revenue Share by Type (2016-2021) Table 42. Global Seasonal Influenza Vaccines Price (USD/Unit) by Type (2016-2021) Table 43. Global Seasonal Influenza Vaccines Sales (K Units) by Application (2016-2021) Table 44. Global Seasonal Influenza Vaccines Sales Market Share by Application (2016-2021) Table 45. Global Seasonal Influenza Vaccines Revenue (Million US$) by Application (2016-2021) Table 46. Global Seasonal Influenza Vaccines Revenue Share by Application (2016-2021) Table 47. Global Seasonal Influenza Vaccines Price (USD/Unit) by Application (2016-2021) Table 48. GlaxoSmithKline plc Corporation Information Table 49. GlaxoSmithKline plc Description and Business Overview Table 50. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Table 52. GlaxoSmithKline plc Recent Developments/Updates Table 53. Sinovac Biotech Ltd Corporation Information Table 54. Sinovac Biotech Ltd Description and Business Overview Table 55. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Table 57. Sinovac Biotech Ltd Recent Developments/Updates Table 58. Changsheng Bio-Technology Corporation Information Table 59. Changsheng Bio-Technology Description and Business Overview Table 60. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Table 62. Changsheng Bio-Technology Recent Developments/Updates Table 63. Ccbio SA Corporation Information Table 64. Ccbio SA Description and Business Overview Table 65. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Ccbio SA Seasonal Influenza Vaccines Product Table 67. Ccbio SA Recent Developments/Updates Table 68. Aleph Biomedical Corporation Information Table 69. Aleph Biomedical Description and Business Overview Table 70. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Aleph Biomedical Seasonal Influenza Vaccines Product Table 72. Aleph Biomedical Recent Developments/Updates Table 73. Sanofi Corporation Information Table 74. Sanofi Description and Business Overview Table 75. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Sanofi Seasonal Influenza Vaccines Product Table 77. Sanofi Recent Developments/Updates Table 78. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information Table 79. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview Table 80. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Table 82. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments/Updates Table 83. Dalian Hissen Bio-pharm Corporation Information Table 84. Dalian Hissen Bio-pharm Description and Business Overview Table 85. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Table 87. Dalian Hissen Bio-pharm Recent Developments/Updates Table 88. Abbott Laboratories Corporation Information Table 89. Abbott Laboratories Description and Business Overview Table 90. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Abbott Laboratories Seasonal Influenza Vaccines Product Table 92. Abbott Laboratories Recent Developments/Updates Table 93. Novartis International AG Corporation Information Table 94. Novartis International AG Description and Business Overview Table 95. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Novartis International AG Seasonal Influenza Vaccines Product Table 97. Novartis International AG Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Seasonal Influenza Vaccines Distributors List Table 101. Seasonal Influenza Vaccines Customers List Table 102. Seasonal Influenza Vaccines Market Trends Table 103. Seasonal Influenza Vaccines Growth Drivers Table 104. Seasonal Influenza Vaccines Market Challenges Table 105. Seasonal Influenza Vaccines Market Restraints Table 106. Global Seasonal Influenza Vaccines Sales Forecast by Type (2022-2027) & (K Units) Table 107. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Type (2022-2027) Table 108. Global Seasonal Influenza Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million) Table 109. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Type (2022-2027) Table 110. Global Seasonal Influenza Vaccines Sales Forecast by Application (2022-2027) & (K Units) Table 111. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Application (2022-2027) Table 112. Global Seasonal Influenza Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million) Table 113. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Application (2022-2027) Table 114. Global Seasonal Influenza Vaccines Sales Forecast by Region (2022-2027) & (K Units) Table 115. Global Seasonal Influenza Vaccines Sales Market Share Forecast by Region (2022-2027) Table 116. Global Seasonal Influenza Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million) Table 117. Global Seasonal Influenza Vaccines Revenue Market Share Forecast by Region (2022-2027) Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Seasonal Influenza Vaccines Figure 2. Global Seasonal Influenza Vaccines Market Share by Type in 2020 & 2027 Figure 3. Type A (H1N1) Product Picture Figure 4. Type A (H3N2) Product Picture Figure 5. Type B Product Picture Figure 6. Global Seasonal Influenza Vaccines Market Share by Application in 2020 & 2027 Figure 7. Pediatrics Figure 8. Adolescence Figure 9. Adults Figure 10. Elderly Figure 11. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Seasonal Influenza Vaccines Market Size 2016-2027 (US$ Million) Figure 13. Global Seasonal Influenza Vaccines Sales 2016-2027 (K Units) Figure 14. Global Seasonal Influenza Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Seasonal Influenza Vaccines Sales Share by Manufacturers in 2020 Figure 16. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Seasonal Influenza Vaccines Players: Market Share by Revenue in 2020 Figure 18. Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Seasonal Influenza Vaccines Sales Market Share by Region (2016-2021) Figure 20. Global Seasonal Influenza Vaccines Sales Market Share by Region in 2020 Figure 21. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2016-2021) Figure 22. Global Seasonal Influenza Vaccines Revenue Market Share by Region in 2020 Figure 23. U.S. Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. U.A.E Seasonal Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Seasonal Influenza Vaccines by Type (2016-2021) Figure 48. Sales Market Share of Seasonal Influenza Vaccines by Application (2016-2021) Figure 49. Sales Market Share of Seasonal Influenza Vaccines by Application in 2020 Figure 50. Revenue Share of Seasonal Influenza Vaccines by Application (2016-2021) Figure 51. Revenue Share of Seasonal Influenza Vaccines by Application in 2020 Figure 52. Manufacturing Cost Structure of Seasonal Influenza Vaccines Figure 53. Manufacturing Process Analysis of Seasonal Influenza Vaccines Figure 54. Seasonal Influenza Vaccines Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

GlaxoSmithKline plc Sinovac Biotech Ltd Changsheng Bio-Technology Ccbio SA Aleph Biomedical Sanofi Jiangsu Simcere Vaxtec Bio-pharmaceutical Dalian Hissen Bio-pharm Abbott Laboratories Novartis International AG